Global Business Innovation Programme - MedTech and Diagnostics Singapore 2024

Innovate UK invites ambitious MedTech & Diagnostics companies to participate in a Global Business Innovation Programme that will include a market visit to Singapore.

Finance & funding Business support Trading business Newcastle upon Tyne Sunderland County Durham Gateshead South Tyneside North Tyneside Northumberland Markets

Register for this scheme

    This scheme is provided by Innovate UK

    Innovate UK
      www.ukri.org/councils/innovate-uk

      Delivered by Innovate UK, this engaging programme consists of a Get ready preparation phase, 5-day innovation visit to focus on Singapore, an exploitation workshop, and support from an Innovate UK innovation and growth specialist - helping your business to identify opportunities and develop innovation projects with partners in the country.

      Focus Areas: 

      Applications are welcomed from innovative MedTech & Diagnostics companies that focus on but not limited to:

      • Medical Technologies
      • Diagnostics including but not limited to In Vitro Diagnostics (IVDs)
      • Medical Imaging
      • Wearables

      Areas of Focus that are not being considered are:

      • Patient Management Software
      • Digital Health
      • Formulated Therapeutics (* therapeutic delivery devices may be considered)

      Why Singapore?

      Singapore’s Research, Innovation and Enterprise 2025 Plan aims to better transform and protect health, advance human potential & create economic value for Singapore. Priorities include transforming and protecting health through (i) shifting the focus towards both health promotion & disease prevention as the population ages (ii) supporting the health system to become more data-driven and patient-centric to deliver value-based care through the innovative use of both technology and digital solutions at scale (iii) using data analytics to support public health actions & telemedicine to deliver quality care to the wider population and (iv) expanding the national precision medicine research programme. A further priority is maximising economic value by growing a vibrant mix of start-ups and scale-ups with a strong translational ecosystem, with a particular focus on biotech companies.
       
      With the Asia-Pacific Medical Technology (MedTech) market expected to grow to US$225 billion by 2030, Singapore is strategically placed to enable companies to tap into these regional opportunities, and Singapore’s network of top universities, research institutions and innovative start-ups also enable MedTech companies to fully engage with a vibrant open innovation ecosystem.
       
      Singapore has an advanced digital economy and is consistently ranked as one of the world’s most innovative cities. Building on the strong mutual interest in co-innovation between Singapore and the UK, Enterprise Singapore and Innovate UK will be opening the latest round of their bilateral R&D grant funding call, coinciding with the timing of this GBIP visit to Singapore.

      Key dates 

      Applicant Briefing: 25 March 2024 Register here 

      Closing date for applications: 21 April 2024

      Pre-visit briefing(s): 20 & 21 May 2024

      Innovation visit: 1 – 5 July 2024

      Post-visit workshop: September 2024


      Can't find what you're looking for?

      Get in touch with the team using the form below

      * Required field